{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:41:53Z","timestamp":1773297713632,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2002,12,1]]},"DOI":"10.1038\/sj.jhh.1001496","type":"journal-article","created":{"date-parts":[[2003,1,9]],"date-time":"2003-01-09T15:46:07Z","timestamp":1042127167000},"page":"819-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension"],"prefix":"10.1038","volume":"16","author":[{"given":"R","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Morse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Reisin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,12,23]]},"reference":[{"key":"BF1001496_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/jama.1994.03520030047027","volume":"272","author":"RJ Kuczmarski","year":"1994","unstructured":"Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL . Increasing prevalence of overweight among US adults. The national health and nutrition examination surveys, 1960 to 1991 JAMA 1994 272: 205\u2013211","journal-title":"JAMA"},{"key":"BF1001496_CR2","first-page":"53","volume":"72","author":"HB Hubert","year":"1983","unstructured":"Hubert HB, Feinleib M, McNamara PM, Castelli WP . Obesity as an independent risk factor for cardio-vascular disease: a 26-year follow-up of participants in the Framingham heart study Circulation 1983 72: 53\u201360","journal-title":"Circulation"},{"key":"BF1001496_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7326\/0003-4819-67-1-48","volume":"67","author":"WB Kannel","year":"1967","unstructured":"Kannel WB et al. The relation of adiposity to blood pressure and development of hypertension. The Framingham Study Ann Intern Med 1967 67: 48\u201359","journal-title":"Ann Intern Med"},{"key":"BF1001496_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199801013380101","volume":"338","author":"J Stevens","year":"1997","unstructured":"Stevens J et al. The effect of age on the association between body-mass index and mortality N Engl J Med 1997 338: 1\u20137","journal-title":"N Engl J Med"},{"key":"BF1001496_CR5","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","volume":"59","author":"N Kambham","year":"2001","unstructured":"Kambham N et al. Obesity-related glomerulopathy: an emerging epidemic Kidney Int 2001 59: 1498\u20131509","journal-title":"Kidney Int"},{"key":"BF1001496_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0002-9149(75)90835-8","volume":"35","author":"AL Johnson","year":"1975","unstructured":"Johnson AL et al. Influence of race, sex and weight on blood pressure behavior in young adults Am J Cardial 1975 35: 523\u2013530","journal-title":"Am J Cardial"},{"key":"BF1001496_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/S0895-7061(00)01254-1","volume":"13","author":"R Zhang","year":"2000","unstructured":"Zhang R, Reisin E . Obesity hypertension: the effects on cardiovascular and renal systems Am J Hypertens 2000 13: 1308\u20131314","journal-title":"Am J Hypertens"},{"key":"BF1001496_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0033-0620(99)70008-3","volume":"42","author":"N Mikhail","year":"1999","unstructured":"Mikhail N, Golub MS, Tuck ML . Obesity and hypertension Prog Cardiovasc Dis 1999 42: 39\u201358","journal-title":"Prog Cardiovasc Dis"},{"key":"BF1001496_CR9","doi-asserted-by":"publisher","first-page":"49S","DOI":"10.1016\/S0895-7061(97)00075-7","volume":"10","author":"JE Hall","year":"1997","unstructured":"Hall JE . Mechanism of abnormal renal sodium handling in obesity hypertension Am J Hypertens 1997 10: 49S\u201355S","journal-title":"Am J Hypertens"},{"key":"BF1001496_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/01.HYP.22.3.292","volume":"22","author":"J Hall","year":"1993","unstructured":"Hall J, Brands M, Dixon W . Obesity-induced hypertension: renal function and systemic hemodynamics Hypertension 1993 22: 292\u2013299","journal-title":"Hypertension"},{"key":"BF1001496_CR11","doi-asserted-by":"crossref","unstructured":"The Sixth Report of the Joint National Committee on the prevention, detection, evaluation, and treatment of high blood pressure Arch Intern Med 1997 157: 2413\u20132446","DOI":"10.1001\/archinte.157.21.2413"},{"key":"BF1001496_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMra012586","volume":"346","author":"SZ Yanovski","year":"2002","unstructured":"Yanovski SZ, Yanovski JA . Drug therapy: obesity N Engl J Med 2002 346: 591\u2013602","journal-title":"N Engl J Med"},{"key":"BF1001496_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM197801052980101","volume":"298","author":"E Reisin","year":"1978","unstructured":"Reisin E et al. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients N Engl J Med 1978 298: 1\u20136","journal-title":"N Engl J Med"},{"key":"BF1001496_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1001\/jama.1985.03350290063027","volume":"253","author":"HG Landgford","year":"1985","unstructured":"Landgford HG et al. Dietary therapy slows the return of hypertension after stopping prolonged medication JAMA 1985 253: 657\u2013664","journal-title":"JAMA"},{"key":"BF1001496_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/jama.279.11.839","volume":"279","author":"PK Whelton","year":"1998","unstructured":"Whelton PK et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE collaborative research group JAMA 1998 279: 839\u2013846","journal-title":"JAMA"},{"key":"BF1001496_CR16","doi-asserted-by":"crossref","unstructured":"Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high\u2013normal blood pressure. The trials of hypertension prevention, phase 2. The trials of hypertension prevention collaborative research group Arch Intern Med 1997 157: 657\u2013667","DOI":"10.1001\/archinte.157.6.657"},{"key":"BF1001496_CR17","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7326\/0003-4819-87-6-714","volume":"87","author":"SM Genet","year":"1977","unstructured":"Genet SM . Insulin secretion in obesity and diabetes: an illustrative case Ann Intern Med 1977 87: 714\u2013716","journal-title":"Ann Intern Med"},{"key":"BF1001496_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJM197110072851504","volume":"285","author":"N Grey","year":"1971","unstructured":"Grey N, Kilns DM . Effect of diet composition on the hyperinsulinemia of obesity N Engl J Med 1971 285: 827\u2013831","journal-title":"N Engl J Med"},{"key":"BF1001496_CR19","first-page":"1447","volume":"13","author":"P Eggena","year":"1991","unstructured":"Eggena P et al. Hormonal correlates of weight loss associated with blood pressure reduction Clin Exp Hypertens 1991 13: 1447\u20131456","journal-title":"Clin Exp Hypertens"},{"key":"BF1001496_CR20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1056\/NEJM198104163041602","volume":"304","author":"ML Tuck","year":"1981","unstructured":"Tuck ML et al. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients N Engl J Med 1981 304: 930\u2013933","journal-title":"N Engl J Med"},{"key":"BF1001496_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/01.CIR.45.2.310","volume":"45","author":"JK Alexander","year":"1972","unstructured":"Alexander JK, Peterson KL . Cardiovascular effects of weight reduction Circulation 1972 45: 310\u2013318","journal-title":"Circulation"},{"key":"BF1001496_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.7326\/0003-4819-98-3-315","volume":"98","author":"E Reisin","year":"1983","unstructured":"Reisin E et al. Cardiovascular changes after weight reduction in obesity hypertension Ann Intern Med 1983 98: 315\u2013319","journal-title":"Ann Intern Med"},{"key":"BF1001496_CR23","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1161\/01.HYP.23.5.600","volume":"23","author":"G de Simon","year":"1994","unstructured":"de Simon G et al. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults Hypertension 1994 23: 600\u2013606","journal-title":"Hypertension"},{"key":"BF1001496_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJM198602063140602","volume":"314","author":"SW MacMahon","year":"1986","unstructured":"MacMahon SW, Wilcken DE, MacDonald GJ . The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patients N Engl J Med 1986 314: 334\u2013339","journal-title":"N Engl J Med"},{"key":"BF1001496_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.0954-6820.1979.tb06066.x","volume":"205","author":"L Backman","year":"1979","unstructured":"Backman L, Freyschuss V, Hallberg D, Melcher A . Reversibility of cardiovascular changes in extreme obesity Acta Med Scand 1979 205: 367\u2013373","journal-title":"Acta Med Scand"},{"key":"BF1001496_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/ki.1992.338","volume":"42","author":"S Kovayashi","year":"1992","unstructured":"Kovayashi S, Venkatachalam MA . Differential effects of calorie restriction on glomeruli and tubules of the remnant kidney Kidney Int 1992 42: 710\u2013717","journal-title":"Kidney Int"},{"key":"BF1001496_CR27","first-page":"710","volume":"21","author":"E Reisin","year":"1993","unstructured":"Reisin E et al. Low caloric unrestricted protein diet attenuates renal injury in hypertensive rats Hyper-tension 1993 21: 710\u2013717","journal-title":"Hyper-tension"},{"key":"BF1001496_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000013491","volume":"19","author":"E Reisin","year":"1999","unstructured":"Reisin E et al. A low-calorie unrestricted protein diet attenuates kidney damage in uninephrectomized spontaneously hypertensive rats Am J Nephrol 1999 19: 433\u2013440","journal-title":"Am J Nephrol"},{"key":"BF1001496_CR29","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/j.1523-1755.2000.00384.x","volume":"58","author":"M Praga","year":"2000","unstructured":"Praga M et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy Kidney Int 2000 58: 2111\u20132118","journal-title":"Kidney Int"},{"key":"BF1001496_CR30","first-page":"231A","volume":"12","author":"E Morales","year":"2001","unstructured":"Morales E et al. Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies J Am Soc Nephrol 2001 12: 231A","journal-title":"J Am Soc Nephrol"},{"key":"BF1001496_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199602013340503","volume":"334","author":"RV Considine","year":"1996","unstructured":"Considine RV et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans N Engl J Med 1996 334: 292\u2013295","journal-title":"N Engl J Med"},{"key":"BF1001496_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0895-7061(00)01279-6","volume":"14","author":"K Masuo","year":"2001","unstructured":"Masuo K, Mikami H, Ogihara T, Tuck ML . Weight reduction and pharmacologic treatment in obese hypertensives Am J Hypertens 2001 14: 530\u2013538","journal-title":"Am J Hypertens"},{"key":"BF1001496_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1046\/j.1523-1755.1999.00626.x","volume":"56","author":"G Wolf","year":"1999","unstructured":"Wolf G et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis Kidney Int 1999 56: 860\u2013872","journal-title":"Kidney Int"},{"key":"BF1001496_CR34","first-page":"296","volume":"11","author":"P Dessi-Fulgheri","year":"1998","unstructured":"Dessi-Fulgheri P, Sarzani R, Rappelli A . The natriuretic peptide system in obesity-related hypertension: new pathophysiology aspects J Nephrol 1998 11: 296\u2013299","journal-title":"J Nephrol"},{"key":"BF1001496_CR35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF03349021","volume":"19","author":"R Sarzani","year":"1996","unstructured":"Sarzani R et al. Expression of natriuretic peptide receptors in human adipose and other tissues J Endocrinol Invest 1996 19: 581\u2013585","journal-title":"J Endocrinol Invest"},{"issue":"Suppl 5","key":"BF1001496_CR36","first-page":"S114","volume":"11","author":"R Sarzani","year":"1993","unstructured":"Sarzani R et al. A comparative analysis of atrial natriuretic peptide receptor expression on rat tissue J Hypertens 1993 11: (Suppl 5) S114\u2013S116","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"BF1001496_CR37","first-page":"120","volume":"23","author":"G Licata","year":"1994","unstructured":"Licata G, Volpe M, Scaglione R, Rubattu S . Salt-retaining hormones in young normotensive obese subjects. Effects of saline load Hypertension 1994 23: (Suppl 1) 120\u2013124","journal-title":"Hypertension"},{"key":"BF1001496_CR38","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/00004872-199209000-00019","volume":"10","author":"E Maoz","year":"1992","unstructured":"Maoz E et al. The role of atrial natriuretic peptide in the natriuresis of fasting J Hypertens 1992 10: 1041\u20131044","journal-title":"J Hypertens"},{"key":"BF1001496_CR39","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1097\/00004872-199715120-00074","volume":"15","author":"P Dessi-Fulgheri","year":"1997","unstructured":"Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients J Hypertens 1997 15: 1695\u20131699","journal-title":"J Hypertens"},{"key":"BF1001496_CR40","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1139\/y86-143","volume":"64","author":"J Dunbar","year":"1986","unstructured":"Dunbar J . Practical aspects of dietary management of hypertension compliance Can J Physiol Pharmacol 1986 64: 831\u2013835","journal-title":"Can J Physiol Pharmacol"},{"issue":"Suppl 3","key":"BF1001496_CR41","first-page":"S59","volume":"10","author":"RJ Richard","year":"1996","unstructured":"Richard RJ, Thakur V, Reisin E . Obesity related hypertension: its physiology basis and pharmacological approaches to its treatment J Hum Hypertens 1996 10: (Suppl 3) S59\u2013S64","journal-title":"J Hum Hypertens"},{"key":"BF1001496_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1161\/01.HYP.30.1.140","volume":"30","author":"E Reisin","year":"1997","unstructured":"Reisin E et al. Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multi center placebo-controlled trial. Treatment in obese patients with hypertension (TROPHY) Hypertension 1997 30: 140\u2013145","journal-title":"Hypertension"},{"key":"BF1001496_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0895-7061(95)00055-T","volume":"8","author":"GM Reaven","year":"1995","unstructured":"Reaven GM et al. Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure Am J Hypertens 1995 8: 461\u2013466","journal-title":"Am J Hypertens"},{"key":"BF1001496_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0378-5122(98)00037-1","volume":"30","author":"M Stimpel","year":"1998","unstructured":"Stimpel M, Koch B, Weber MA . Comparison between moexipril and atenolol in obese postmenopausal women with hypertension Maturitas 1998 30: 67\u201377","journal-title":"Maturitas"},{"key":"BF1001496_CR45","doi-asserted-by":"crossref","unstructured":"The SOLVD investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 1992 327: 685","DOI":"10.1056\/NEJM199209033271003"},{"key":"BF1001496_CR46","doi-asserted-by":"crossref","unstructured":"The CONSENSUS trial group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavia Enalapril Survival Study (CONSENSUS) N Engl J Med 1987 316: 1429","DOI":"10.1056\/NEJM198706043162301"},{"key":"BF1001496_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1053\/euhj.1998.1098","volume":"20","author":"K Swedberg","year":"1999","unstructured":"Swedberg K, Kjekshus J, Snapinn S for the CONSENSUS investigators. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS 1 Eur Heart J 1999 20: 136","journal-title":"Eur Heart J"},{"key":"BF1001496_CR48","doi-asserted-by":"crossref","unstructured":"The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effect of Ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 1993 342: 821","DOI":"10.1016\/0140-6736(93)92693-N"},{"key":"BF1001496_CR49","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","volume":"275","author":"RE Schmieder","year":"1996","unstructured":"Schmieder RE, Martus P, Klingbeil A . Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies JAMA 1996 275: 1507","journal-title":"JAMA"},{"key":"BF1001496_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.jhh.1000434","volume":"11","author":"G Paolisso","year":"1997","unstructured":"Paolisso G et al. Losartan mediated improvement in insulin action is mainly due to an increase in non-oxidative glucose metabolism and blood flow in insulin-resistant hypertensive patients J Hum Hypertens 1997 11: 307\u2013312","journal-title":"J Hum Hypertens"},{"key":"BF1001496_CR51","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ et al. Collaborative study group: renal protective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 2001 345: 851\u2013860","journal-title":"N Engl J Med"},{"key":"BF1001496_CR52","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM et al and RENAAL study investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 2001 345: 861\u2013879","journal-title":"N Engl J Med"},{"key":"BF1001496_CR53","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1056\/NEJMoa011489","volume":"345","author":"HH Parving","year":"2001","unstructured":"Parving HH et al. Irbesartan in patients with type 2 diabetes and microalbuminuria study group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 2001 345: 870\u2013878","journal-title":"N Engl J Med"},{"key":"BF1001496_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00004872-200018010-00013","volume":"18","author":"LM Ruilope","year":"2000","unstructured":"Ruilope LM, Aldigier JC, Ponticelli C . Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European group for the investigation of valsartan in chronic renal disease J Hypertens 2000 18: 89","journal-title":"J Hypertens"},{"key":"BF1001496_CR55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/00004872-199205000-00013","volume":"10","author":"E Reisin","year":"1992","unstructured":"Reisin E, Weed SG . The treatment of obese hypertensive black women: a comparative study of chlorthalidone versus clonidine J Hypertens 1992 10: 489\u2013493","journal-title":"J Hypertens"},{"key":"BF1001496_CR56","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/0003-4819-123-7-199510010-00001","volume":"123","author":"AW Hoes","year":"1995","unstructured":"Hoes AW, Grobbee DE, Lubsen JL . Diuretics, beta blockers, and the risk for sudden cardiac death in hypertensive patients Ann Intern Med 1995 123: 481","journal-title":"Ann Intern Med"},{"key":"BF1001496_CR57","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/archinte.1991.00400070114014","volume":"151","author":"JH Warram","year":"1991","unstructured":"Warram JH, Laffel LM, Valsania P . Excess mortality associated with diuretics theraphy in diabetes mellitus Arch Intern Med 1991 151: 1350","journal-title":"Arch Intern Med"},{"key":"BF1001496_CR58","doi-asserted-by":"crossref","unstructured":"SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension JAMA 1991 265: 3255","DOI":"10.1001\/jama.1991.03460240051027"},{"key":"BF1001496_CR59","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/ndt\/13.7.1682","volume":"13","author":"H Buter","year":"1998","unstructured":"Buter H, Hemmelder MH, Navis G . The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide Nephrol Dial Transplant 1998 13: 1682","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl I","key":"BF1001496_CR60","first-page":"1","volume":"19","author":"ML Tuck","year":"1992","unstructured":"Tuck ML . Obesity, the sympathetic nervous system, and essential hypertension Hypertension 1992 (Suppl I) 19: 1\u201367 1\u201377","journal-title":"Hypertension"},{"key":"BF1001496_CR61","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","volume":"92","author":"CD Furberg","year":"1995","unstructured":"Furberg CD, Psaty BM, Meyer JV . Nifedipine, dose-related increase in mortality in patients with coronary heart disease Circulation 1995 92: 1326\u20131331","journal-title":"Circulation"},{"key":"BF1001496_CR62","doi-asserted-by":"publisher","first-page":"S333","DOI":"10.1093\/ajh\/3.10.333","volume":"3","author":"ML Tuck","year":"1990","unstructured":"Tuck ML, Bravo EL, Krakoff LR, Friedman CP . Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension: results of a multicenter trial. The modern approach to the treatment of hypertension study group Am J Hypertens 1990 3: S333\u2013S341","journal-title":"Am J Hypertens"},{"key":"BF1001496_CR63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/BF00315543","volume":"44","author":"M de Courten","year":"1993","unstructured":"de Courten M et al. Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension Eur J Clin Pharmacol 1993 44: 457\u2013462","journal-title":"Eur J Clin Pharmacol"},{"key":"BF1001496_CR64","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0026-0495(97)90298-5","volume":"46","author":"J Cabezas-Cerrato","year":"1997","unstructured":"Cabezas-Cerrato J, Garcia-Estevez DA, Arujo D, Iglesias M . Insulin sensitivity, glucose effectiveness and B-cell function in obese males with essential hypertension: investigation of the effects of treatment with a calcium channel blocker diltiazem or an angiotensin-converting enzyme inhibitor quinopril metabolism Metabolism 1997 46: 173\u2013178","journal-title":"Metabolism"},{"key":"BF1001496_CR65","first-page":"178","volume":"76","author":"NA Beer","year":"1993","unstructured":"Beer NA et al. Effects of nitredipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin resistant obese and hypertensive men J Clin Endocrinol Metab 1993 76: 178\u2013183","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1001496_CR66","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/0002-9149(91)90944-G","volume":"67","author":"S Yusuf","year":"1991","unstructured":"Yusuf S, Held P, Furberg C . Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial and other recent studies Am J Cardiol 1991 67: 1295","journal-title":"Am J Cardiol"},{"key":"BF1001496_CR67","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1681\/ASN.V22s21","volume":"2","author":"GL Bakris","year":"1991","unstructured":"Bakris GL . The effects of calcium antagonists on renal hemodynamics, urinary protein excretion, and glomerular morphology in diabetic states J Am Soc Nephrol 1991 2: S21","journal-title":"J Am Soc Nephrol"},{"key":"BF1001496_CR68","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1681\/ASN.V9112096","volume":"9","author":"P Ruggenenti","year":"1998","unstructured":"Ruggenenti P, Perna A, Benini R, Remuzzi G for the GISEN group. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibitors and blood pressure control on chronic, nondiabetic nephropathies J Am Soc Nephrol 1998 9: 2096","journal-title":"J Am Soc Nephrol"},{"key":"BF1001496_CR69","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/ndt\/10.4.497","volume":"10","author":"RT Gansevoort","year":"1995","unstructured":"Gansevoort RT, Sluiter WJ, Hemmelder MH . Antiproteinuric effect of blood pressure lowering agents: a meta-analysis of comparative trials Nephrol Dial Transplant 1995 10: 1963","journal-title":"Nephrol Dial Transplant"},{"key":"BF1001496_CR70","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/ki.1996.480","volume":"56","author":"GL Bakris","year":"1996","unstructured":"Bakris GL et al. Calcium channel blockers versus other antihypertensive therapies on progression of non-insulin-dependent diabetes mellitus associated nephropathy Kidney Int 1996 56: 1641\u20131650","journal-title":"Kidney Int"},{"key":"BF1001496_CR71","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1046\/j.1523-1755.1999.00434.x","volume":"55","author":"KA Griffin","year":"1999","unstructured":"Griffin KA, Picken MM, Bakris GL, Bidani AK . Class differences in the effects of calcium channel blockers in the rat remnant kidney model Kidney Int 1999 55: 1849\u20131860","journal-title":"Kidney Int"},{"key":"BF1001496_CR72","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/01.HYP.28.1.109","volume":"28","author":"JJ Saseen","year":"1996","unstructured":"Saseen JJ et al. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension Hypertension 1996 28: 109\u2013114","journal-title":"Hypertension"},{"key":"BF1001496_CR73","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0140-6736(85)92310-4","volume":"1","author":"SW MacMahon","year":"1985","unstructured":"MacMahon SW et al. Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients Lancet 1985 1: 1233\u20131236","journal-title":"Lancet"},{"key":"BF1001496_CR74","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/bmj.307.6903.537","volume":"307","author":"RE Schmieder","year":"1993","unstructured":"Schmieder RE et al. Obesity as a determinant for response to antihypertensive treatment BMJ 1993 307: 537\u2013540","journal-title":"BMJ"},{"key":"BF1001496_CR75","first-page":"S23","volume":"4","author":"E Reisin","year":"1999","unstructured":"Reisin E, Tuck ML . Obesity-associated hypertension: hypothesized link between etiology and selection of therapy Blood Pres Monit 1999 4: S23\u2013S26","journal-title":"Blood Pres Monit"},{"key":"BF1001496_CR76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/01.HYP.19.4.393","volume":"19","author":"BR Davis","year":"1992","unstructured":"Davis BR et al. Effect of antihypertensive therapy on weightloss Hypertension 1992 19: 393\u2013399","journal-title":"Hypertension"},{"key":"BF1001496_CR77","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemamtle","year":"1999","unstructured":"Freemamtle N, Cleland J, Young P . Beta-blockade after myocardial infarction: systemic review and meta regression analysis BMJ 1999 318: 1730","journal-title":"BMJ"},{"key":"BF1001496_CR78","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ki.1980.145","volume":"18","author":"VM Campese","year":"1980","unstructured":"Campese VM et al. Role of sympathetic nerve inhibition and body sodium volume state in the antihypertensive action of clonidine in essential hypertension Kidney Int 1980 18: 351\u2013357","journal-title":"Kidney Int"},{"key":"BF1001496_CR79","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJM197902013000505","volume":"300","author":"J Koch-Weser","year":"1979","unstructured":"Koch-Weser J, Graham RM, Pettinger WAS . Drug therapy: prazosin N Engl J Med 1979 300: 232\u2013236","journal-title":"N Engl J Med"},{"key":"BF1001496_CR80","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF00271585","volume":"31","author":"T Pollare","year":"1988","unstructured":"Pollare T, Lithell H, Selinus L, Berne C . Application of prozosin is associated with an increase of insulin sensitivity in obese patients with hypertension Diabetologia 1988 31: 415\u2013420","journal-title":"Diabetologia"},{"key":"BF1001496_CR81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1023\/A:1007735420758","volume":"11","author":"G Bonner","year":"1997","unstructured":"Bonner G, Schmieder R, Chrosch R, Weidinger G . Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension Cardiovasc Drugs Ther 1997 11: 21\u201326","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF1001496_CR82","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S0895-7061(01)01293-6","volume":"14","author":"MR Wofford","year":"2001","unstructured":"Wofford MR et al. Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects Am J Hypertens 2001 14: 694\u2013698","journal-title":"Am J Hypertens"},{"key":"BF1001496_CR83","doi-asserted-by":"crossref","unstructured":"ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlothalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) JAMA 2000 283: 1967\u20131975","DOI":"10.1001\/jama.283.15.1967"},{"key":"BF1001496_CR84","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0272-6386(12)80116-8","volume":"18","author":"ME Rosenberg","year":"1991","unstructured":"Rosenberg ME, Hostetter TH . Comparative effects of antihypertensive on proteinuria: Angiotensin-converting enzyme inhibitor versus alpha1-antagonist Am J Kidney Dis 1991 18: 472","journal-title":"Am J Kidney Dis"},{"key":"BF1001496_CR85","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","volume":"36","author":"GL Bakris","year":"2000","unstructured":"Bakris GL et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach Am J Kidney Dis 2000 36: 646\u2013661","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001496.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001496","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001496.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T15:33:54Z","timestamp":1647531234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,1]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12,1]]}},"alternative-id":["BF1001496"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001496","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,1]]},"assertion":[{"value":"23 December 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}